SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-17-000412
Filing Date
2017-09-18
Accepted
2017-09-18 15:41:01
Documents
4
Period of Report
2017-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR 09-12-2017 form_8-k.htm 8-K 12925
2 PRESS RELEASE ex_99-1.htm EX-99 10345
3 GRAPHIC angiosoma_logo.jpg GRAPHIC 28901
4 GRAPHIC ex_99-1.jpg GRAPHIC 50233
  Complete submission text file 0001161697-17-000412.txt   133814
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 171089914
SIC: 2834 Pharmaceutical Preparations